Levers Health review

What it is

Levers Health LLC is a direct-to-consumer platform positioned as "personalized performance medicine", organised by goal — anti-aging, lean muscle, weight loss, more energy, better skin and hair. Its products are sermorelin, NAD+ injection, lipotropic B-12 MIC+, a compounded GHK-Cu peptide skin cream, compounded semaglutide and tirzepatide, and a low-dose and microdose GLP-1 line marketed for longevity and metabolic optimisation. Every plan is described as reviewed and prescribed by a licensed physician in your state, with medication from US-based, independently tested pharmacies and unlimited clinical support and check-in calls.

How it works

Storefront-first with a clinical review behind it: you check out with the plan you want, complete online health-history forms, a licensed physician reviews and prescribes if appropriate, and the medication ships for self-administration at home. A free introductory call with what the site calls a peptide specialist is offered before you commit, which is a reasonable way to ask the questions the pages do not answer. Free shipping is stated sitewide and cancellation is described as available at any time. The disclosure picture is mixed and worth being precise about. The operating entity is named — Levers Health LLC — and its terms of service resolve, which corrects an earlier reading that its policy pages were dead. But there is no LegitScript certification, no PCAB accreditation, no physical address, no named medical director and no state list, and the pharmacies are described as "US-based, independently tested" without being named. The site also runs recurring first-order promotional codes, so the standing rate rather than the promotional one is the number to budget against.

Pricing transparency

Published up front for every product, which is the point of the site. Sermorelin is a flat $247 a month. NAD+ injection is from $247 a month. Lipotropic B-12 MIC+ is from $137. On the GLP-1 side, semaglutide runs $247 a month for the regular tier and $297 for the higher-dose Max tier, tirzepatide is $396 a month on the any-dose monthly plan and $296 on the up-to-5mg low-dose plan, and the microdose line is billed and shipped at $246 every other month — marketed as "as low as $123/month", which is an amortisation of a bi-monthly charge rather than a monthly price, and worth reading twice. The GHK-Cu cream's price is not shown on the description we reviewed; its page does state what you get, which is 30 g of a 3.0% GHK-Cu acetate formulation per one-month supply. Compare that concentration against any other prescription copper-peptide product before comparing prices, because concentration is the variable that actually differs. First-order promo codes appear regularly; they do not change the ongoing rate.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Levers states in its own footer that medications including compounded options may be prescribed by independent physicians and fulfilled through a state-licensed pharmacy, and that the FDA does not review or approve compounded medications — the right disclosure, though it names no pharmacy, and compounded sterile products are not reviewed by the FDA for purity and potency. On evidence: sermorelin is a GHRH analogue that stimulates the pituitary to release your own growth hormone, preserving the feedback loop that exogenous HGH overrides — a real mechanism whose long-term human outcome data remains thin, which is worth weighing against a $247 standing charge. Injected NAD⁺ has no controlled human outcome trials; the oral precursors NR and NMN are the forms with human data, and they raise blood NAD⁺ rather than demonstrating an outcome. GHK-Cu is a copper-binding tripeptide with an interesting laboratory story in collagen synthesis and wound repair and essentially no controlled human outcome trials — a 3.0% concentration is six times what the site says other clinics use, which raises the dose without supplying the missing evidence. Individual results vary.

Pros and watch-outs

The evidence behind what Levers Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

How Levers Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• KIKina

  A named, topical GHK-Cu peptide inside a menopause practice with named physicians

  See Kina →
• KOKongo

  NAD⁺ injections at a published flat rate across all 50 states

  See Kongo →
• LTLttl

  Shoppers who want every commitment tier priced openly before they hand over anything

  See Lttl →